MRD
13 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Risk-stratified Therapy Based on Molecular Cytogenetic Aberration and Treatment Response in AML (NCT03620955) | Nanfang Hospital, Southern Medical University | 2018-08-10 |
| A Prospective Multicenters Clinical Cohort Study of Stratified Treatment of Chinese Children With Systemic ALK(+) ALCL (NCT03971305) | Sun Yat-sen University | 2017-05-05 |
| Individual Molecular MRD Monitoring for MDS Patients After Allo-SCT (NCT02872662) | Nordic MDS Group | 2016-08-01 |
Track MRD automatically
Every clearance here is in the API, with alerts when new ones post.